Procedureless Gastric Balloon Encourages Weight Loss 
|
By HospiMedica International staff writers Posted on 23 Dec 2015 |
|
Image: The Elipse procedureless gastric balloon (Photo courtesy of Allurion Technologies).S
An innovative gastric balloon offers an alternative treatment option for overweight and obese individuals.
The Elipse procedureless gastric balloon is a thin, flexible polymer film balloon that is delivered in a swallowable capsule, thus eliminating the need for surgery, endoscopy, or anesthesia. Once in position, it is filled with liquid through a thin delivery catheter, which is then detached by tugging. The gastric balloon remains in the stomach for four months, after which it automatically empties and is excreted naturally from the body. The Elipse will be offered by physicians in conjunction with a medically supervised diet and exercise program.
The Elipse has undergone clinical studies in people with a body mass index (BMI) of 27-40 kg/m2. Study findings indicated an average weight loss of 10 kilograms, with participants losing 37% of their excess weight and eight centimeters off their waist circumference over the four month treatment period. Participants also saw improvements in triglyceride and hemoglobin HbA1c levels, and all balloons were safely and naturally excreted. The Elipse procedureless gastric balloon is a product of Allurion Technologies (Wellesley, MA, USA), and has received the European Community CE marking of approval.
“Excess weight often has a profound impact on health and quality of life, including work, relationships, and self-perception. But of nearly two billion overweight and obese adults worldwide, less than one percent have embraced currently available surgical and endoscopic options,” said Shantanu Gaur, MD, co-founder and chief scientific officer of Allurion Technologies. “Weight loss therapies that require surgery, endoscopy, or anesthesia are often too invasive and can be too expensive for people who might otherwise greatly benefit from them.”
“Following six years of development, we are very excited to enter the next phase of our company's growth,” said Jonathan Wecker, CEO of Allurion Technologies. “I am extremely proud of our team and thankful for the support of the many physicians and allied caregivers that have helped make Elipse a reality.”
Related Links:
Allurion Technologies
The Elipse procedureless gastric balloon is a thin, flexible polymer film balloon that is delivered in a swallowable capsule, thus eliminating the need for surgery, endoscopy, or anesthesia. Once in position, it is filled with liquid through a thin delivery catheter, which is then detached by tugging. The gastric balloon remains in the stomach for four months, after which it automatically empties and is excreted naturally from the body. The Elipse will be offered by physicians in conjunction with a medically supervised diet and exercise program.
The Elipse has undergone clinical studies in people with a body mass index (BMI) of 27-40 kg/m2. Study findings indicated an average weight loss of 10 kilograms, with participants losing 37% of their excess weight and eight centimeters off their waist circumference over the four month treatment period. Participants also saw improvements in triglyceride and hemoglobin HbA1c levels, and all balloons were safely and naturally excreted. The Elipse procedureless gastric balloon is a product of Allurion Technologies (Wellesley, MA, USA), and has received the European Community CE marking of approval.
“Excess weight often has a profound impact on health and quality of life, including work, relationships, and self-perception. But of nearly two billion overweight and obese adults worldwide, less than one percent have embraced currently available surgical and endoscopic options,” said Shantanu Gaur, MD, co-founder and chief scientific officer of Allurion Technologies. “Weight loss therapies that require surgery, endoscopy, or anesthesia are often too invasive and can be too expensive for people who might otherwise greatly benefit from them.”
“Following six years of development, we are very excited to enter the next phase of our company's growth,” said Jonathan Wecker, CEO of Allurion Technologies. “I am extremely proud of our team and thankful for the support of the many physicians and allied caregivers that have helped make Elipse a reality.”
Related Links:
Allurion Technologies
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
MRI System
nanoScan MRI 3T/7T
Digital Color Doppler Ultrasound System
MS22Plus
Latest Surgical Techniques News
- New Study Findings Could Halve Number of Stent Procedures
- Breakthrough Surgical Device Redefines Hip Arthroscopy
- Automated System Enables Real-Time "Molecular Pathology" During Cancer Surgery
- Groundbreaking Procedure Combines New Treatments for Liver Tumors
- Ablation Reduces Stroke Risk Associated with Atrial Fibrillation
- Optical Tracking Method Identifies Target Areas in Robot-Assisted Neurosurgery
- General Anesthesia Improves Post-Surgery Outcomes for Acute Stroke Patients
- Drug-Coated Balloons Can Replace Stents Even in Larger Coronary Arteries
- Magnetic Kidney Stone Retrieval Device Outperforms Ureteroscopic Laser Lithotripsy
- Absorbable Skull Device Could Replace Traditional Metal Implants Used After Brain Surgery
- Magic Silicone Liquid Powered Robots Perform MIS in Narrow Cavities
- 'Lab-on-a-Scalpel' Provides Real-Time Surgical Insights for POC Diagnostics in OR
- Biodegradable Brain Implant Prevents Glioblastoma Recurrence
- Tiny 3D Printer Reconstructs Tissues During Vocal Cord Surgery
- Minimally Invasive Procedure for Aortic Valve Disease Has Similar Outcomes as Surgery
- Safer Hip Implant Design Prevents Early Femoral Fractures
Channels
Critical Care
view channel
Magnetically Guided Microrobots to Enable Targeted Drug Delivery
Stroke affects 12 million people globally each year, often causing death or lasting disability. Current treatment relies on systemic administration of clot-dissolving drugs, which circulate throughout... Read more
Smart Nanomaterials Detect and Treat Traumatic Brain Injuries Simultaneously
Traumatic brain injury (TBI) continues to leave millions with long-term disabilities every year. After a sudden impact from a fall, collision, or accident, the brain undergoes inflammation, oxidative stress,... Read more
Earlier Blood Transfusion Could Reduce Heart Failure and Arrhythmia in Heart Disease Patients
Blood loss during or after surgery can place significant stress on people with heart disease, increasing the risk of dangerous complications. Transfusions are often delayed until hemoglobin levels fall... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more